Research article · 27 Jul 2026
Conference abstractPublished 15 Oct 2018
Molecular dynamics model of melatonin and MT1 receptor
Institute of Neurobiology,Bulgaria IOCCP, BAS, BulgariaIBER, BulgariaInstitute of Neurobiology - BAS, Bulgaria
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Melatonin receptor (MT1) is an attractive target for elaboration of new drug candidates, but unfortunately is known to be unstable out of the membrane lipid bilayer, which makes the obtaining of a crystal structure by X-Ray diffraction (XRD) an elusive goal. Up to now, there is no published real structure suitable for docking of new ligands targeting this receptor. However, there are lots of model based on the data from crystallized rhodopsin, but they are too artificial for reasonable docking of drug-like candidate molecules. To overcome these drawbacks, we built an in silico molecular model of a melatonin receptor in membrane bilayer in water cell, with explicit water molecules. For that purpose, we used GROMACS molecular mechanics software with GROMOS force field and TYP3P water model. Calculations were carried out in periodic boundary conditions at 300 K and one bar pressure, physiological NaCl content and pH7. By the simulation, we caught the act of melatonin entering the receptor which enlightened a wide variety of interactions that can facilitate or to disturb the movement of melatonin to the hardly accessible active site of MT1. Molecular docking of the drug like candidates was performed on receptor model. The information can be used along with data obtained from the structure of melatonin-receptor complex to construct new analogs of melatonin, capable not only to activate the receptor but also to successfully manage their way to the MT1 binding site.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Clinical Pharmacology & Biopharmaceutics.
Article · 20 Jul 2026
Population Pharmacology: Precision Dosing for Diverse Patients
Article · 17 Jul 2026
Therapeutic Drug Monitoring: Optimizing Therapy, Minimizing Toxicity
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Pharmacology & Biopharmaceutics
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Violina T Angelova”
- BylineArticles whose byline prints “Miroslav Rangelov”
- BylineArticles whose byline prints “Nadezhda Todorova”
- BylineArticles whose byline prints “Jana Tchekalarova”